A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

Name: A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age
Published: 2023
License: Public Domain

Seqirus · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

influenza vaccine

influenza, human, influenza, vaccine, mf59 adjuvant, aqiv, ativ, a/h1n1, a/h3n2, b/yamagata, b/victoria, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

Related documents